Analysis of TCGA data indicated that ZFAS1 expression was not reduced in breast cancers in general (Additional file 2: Figure S2A i), but suggested that particular subtypes (basal, HER2-positive) show reduced expression (Additional file 2: Figure S2A ii, iii). This evidence concerns the gene ERBB2 and breast carcinoma.